INOVIQ Ltd (ASX:IIQ) (INOVIQ) is a lifesciences company developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions to improve the diagnosis and treatment of cancer and other diseases. The Company has commercialised the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Our cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate and other cancers.